Masashi Tomida
Papers
1
Total Citations
12
H-Index
1
About
Masashi Tomida is a leading figure in the advancement of stereotactic body radiation therapy (SBRT), with a focused expertise in the clinical application of multileaf collimators (MLCs) for robotic radiosurgery systems. His most cited work, a 2017 study on the clinical usefulness of MLCs in prostate SBRT, has garnered 12 citations and represents a pivotal contribution to the field. In this research, Tomida demonstrated that MLCs offer significant advantages over traditional circular collimators for treating localized prostate cancer, enabling more precise dose delivery and improved treatment outcomes. His work has helped establish MLC-based robotic radiosurgery as a preferred technique, directly influencing clinical protocols and enhancing patient care. By systematically comparing these technologies, Tomida provided critical evidence that has shaped modern radiation oncology practices. His contributions underscore a commitment to refining therapeutic precision and expanding the capabilities of SBRT, making him a respected voice in the ongoing evolution of cancer treatment technologies.
Research Focus
Key Achievements
Top Papers
- 1